The MILenARI consortium congratulates Dr. Manel Juan, principal investigator at IDIBAPS, the institution coordinating the project, on being named one of Spain’s Best Doctors 2026 in the field of Immunology by El Confidencial.
The MILenARI consortium congratulates Dr. Manel Juan, principal investigator at IDIBAPS, the institution coordinating the project, on being named one of Spain’s Best Doctors 2026 in the field of Immunology by El Confidencial. Dr. Juan, Head of the Immunology Department at Hospital Clínic de Barcelona, has been recognised for his contributions to cancer immunotherapy and advanced cellular therapies, including CAR-T treatments.
Many of these pioneering CAR-T therapies have been developed and advanced by Dr. Juan and his team in Barcelona. Through MILenARI, this expertise is being shared with leading medical and research centres across the Mediterranean region, helping to expand access to cutting-edge cellular therapies and strengthen local capabilities in advanced immunotherapy.
This recognition highlights not only Dr. Juan’s leadership in translational immunology, but also the scientific excellence underpinning the MILenARI consortium. Coordinated by IDIBAPS, the project brings together leading research institutions from across the Mediterranean region, creating a unique environment for collaboration and innovation in healthy ageing research. Among these institutions, there are the King Hussein Cancer Center (KHCC) in Jordan, the Ospedale Pediatrico Bambino Gesù in Italy, and the American University of Beirut (AUB) in Lebanon.
The consortium warmly congratulates Dr. Juan on this well-deserved achievement.
Last Update
13/10/2026
Next Med